| Aug 8 |
Virios Therapeutics Announces Second Quarter 2024 Financial Results
|
| Aug 1 |
Virios Therapeutics to Report Second Quarter 2024 Financial Results on Thursday, August 8, 2024
|
| Jul 23 |
Virios Therapeutics Announces Completion of Enrollment in IMC-2 Phase 2 Long-COVID Study Being Conducted by Bateman Horne Center
|
| Jul 22 |
Why Tellurian Shares Are Trading Higher By Around 65%; Here Are 20 Stocks Moving Premarket
|
| Jul 18 |
Why Chuy's Holdings Shares Are Trading Higher By 47%; Here Are 20 Stocks Moving Premarket
|
| May 22 |
Virios Therapeutics Announces Closing of $1.7 Million Public Offering of Common Stock to Commence Preparations for Planned IMC-2 Long-COVID Phase 2b Study
|
| May 20 |
Dow Falls Over 150 Points; Sohu Posts Q1 Loss
|
| May 20 |
Nasdaq Surges 100 Points; Wix.com Shares Jump Following Q1 Results
|
| May 20 |
Virios Therapeutics shares slid on pricing public offering of units to raise $1.7M
|
| May 20 |
Virios Therapeutics Announces Pricing of $1.7 Million Public Offering of Common Stock to Commence Preparations for Planned IMC-2 Long-COVID Phase 2b Study
|
